Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Panacea Biotec Limited ( (IN:PANACEABIO) ) has shared an update.
Panacea Biotec Limited announced the publication of a newspaper notice regarding its 41st Annual General Meeting, including details about the cut-off date and remote e-voting. This announcement is part of the company’s compliance with SEBI regulations, ensuring transparency and shareholder engagement in its governance processes.
More about Panacea Biotec Limited
Panacea Biotec Limited is a company operating in the biotechnology and pharmaceutical industry. It is primarily involved in the development, manufacturing, and marketing of pharmaceutical formulations and vaccines, focusing on providing healthcare solutions to improve global health.
Average Trading Volume: 16,386
Technical Sentiment Signal: Buy
Current Market Cap: 24.91B INR
See more insights into PANACEABIO stock on TipRanks’ Stock Analysis page.